ÔÚ°¢¶û´Äº£Ä¬²¡ÁÙ´²ÊÔÑ飨CTAD£©»áÒéÉÏÐû²¼ÁËÊ׸ö×ÊÖúʶ±ðIIIÆÚAHEAD 3-45Ñо¿ÊÜÊÔÕßµÄͬÀàѪ½¬ÉúÎï±êÖ¾Îïɸ²éÒªÁì
ÈÕ±¾¶«¾©ºÍÃÀ¹úÂíÈøÖîÈûÖݽ£ÇÅÊУ¬2021Äê11ÔÂ12ÈÕ-À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾Öêʽ»áÉ磨×ܲ¿£º¶«¾©£¬Ê×ϯִÐй٣ºÄÚÌÙÇç·ò£¬ÒÔϼò³Æ¡°À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾¡±£©ºÍ²³½¡¹«Ë¾£¨Nasdaq£ºBIIB£¬×ܲ¿£ºÂíÈøÖîÈûÖݽ£ÇÅÊУ¬Ê×ϯִÐй٣ºMichel Vounatsos£¬ÒÔϼò³Æ¡°²³½¡¡±£©Ðû²¼ÁËÒ»Ïî̽Ë÷ÔÚLecanemab£¨BAN2401£©£¨Ò»ÖÖÊÔÑéÐÔ¿¹µí·ÛÑùÂѰצ [A¦Â]ÔÏËά¿¹Ì壩µÄIIIÆÚAHEAD 3-45Ñо¿ÖÐʹÓÃѪ½¬ÉúÎï±êÖ¾ÎïµÄÑо¿½á¹û¡£AHEAD 3-45ÊÇÊ׸öʹÓÃÕâЩÉúÎï±êÖ¾Îï¼ì²â°¢¶û´Äº£Ä¬²¡£¨AD£©²¡Àí²¢¿ÉÄܼÓËÙɸ²é¹ý³ÌµÄÁÙ´²Ç°ADÊÔÑé¡£°¢¶û´Äº£Ä¬²¡ÁÙ´²ÊÔÑéÁªÃË£¨ACTC£©ÔÚ2021Äê11ÔÂ9ÈÕÖÁ12ÈÕÔÚÂíÈøÖîÈûÖݲ¨Ê¿¶Ù¾ÙÐеÄ2021Äê°¢¶û´Äº£Ä¬²¡ÁÙ´²ÊÔÑ飨CTAD£©»áÒéÉÏÐû²¼ÁË´ËÑо¿½á¹û¡£